Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
08/2003
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334084A2 Phosgene-free process for preparing carbamates
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1333795A1 Novel coupler for use in oxidative hair dyeing
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
08/13/2003EP0946504B1 Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compounds
08/13/2003CN1436170A Vitamin D derivs.
08/12/2003US6605677 Olefin polymerization processes using supported catalysts
08/12/2003US6605635 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605608 Amino acid derivatives and drugs containing the same as the active ingredient
08/12/2003US6605124 Naphthol hair dyes for keratinous fibers
08/07/2003WO2003064402A1 Treatment of male sexual dysfunction
08/07/2003WO2003064378A2 Novel compounds that inhibit factor xa activity
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063852A1 Therapeutic agent for urinary incontinence
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/07/2003US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149021 For therapy of cancer, as antibacterial, as insecticide
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
08/07/2003US20030147845 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
08/07/2003CA2474590A1 Treatment of male sexual dysfunction
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2473164A1 Novel compounds that inhibit factor xa activity
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1333024A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
08/06/2003EP1332138A1 Radiopharmaceuticals for diagnosing alzheimer's disease
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434796A Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
08/06/2003CN1434724A Remedies and/or preventives for nervous system disorders
08/06/2003CN1434034A Amidemercaptan and thioderivative thereof
08/06/2003CN1117095C Antibacterial substituted 7-2cylamino-3(methylhydrazono) methyl-cephalosponins and intermediates
08/05/2003US6603022 Reacting Lovastatin with a secondary amine under suitable conditions to form the corresponding amide intermediate, methylating the C-8 butyrate side chain, hydrolyzing to free carboxylic acid; lactonization
08/05/2003US6603003 Method for the preparation of piperazine and its derivatives
08/05/2003US6602869 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
07/2003
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003WO2003061660A1 Melanocortin receptor agonists
07/31/2003WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors
07/31/2003WO2003002596A3 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003US20030144505 Novel compounds
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144323 Phenylalkynes
07/31/2003US20030144299 Method of treating depression with delta receptor agonist compounds
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/31/2003US20030144291 Substituted indan derivatives
07/31/2003US20030144285 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics
07/31/2003US20030144267 Novel compounds
07/31/2003US20030144265 HIV protease inhibitors based on amino acid derivatives
07/31/2003US20030144261 A cyclic peptide useful for treating eating disorder and diabetes
07/31/2003US20030144234 Administering a cathepsin modulator or enzyme inhibitor, select from a mRNA or a protein; gene expression inhibition, analgesics
07/31/2003US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand
07/31/2003US20030143481 Image forming material and ammonium compound
07/31/2003US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
07/31/2003CA2473036A1 Melanocortin receptor agonists
07/30/2003EP1330233A1 Method of treating stroke
07/30/2003EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/30/2003EP0592439B1 Aminosulfonyl carbamates
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433407A Bis-arylsulfones
07/30/2003CN1433396A Pharmaceutical compounds
07/29/2003US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them
07/29/2003US6599942 Method of lowering LDL cholesterol and Lipoprotein a levels in mammals using such compounds
07/29/2003US6599932 Highly selective in killing tumor cells but not normal cells
07/29/2003US6599921 Antiproliferative agents against estrogen-dependent cancer cells dibenzothiopyran, dibenzopyran and phenanthrene derivatives
07/29/2003US6599920 Antiestrogenic compound having fewer or no estrogen agonist properties on reproductive tissues
07/29/2003US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments
07/29/2003US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/29/2003CA2188690C Selective thrombin inhibitors
07/24/2003WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/24/2003WO2003059335A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003WO2003059265A2 Compositions and methods for treating heart failure
07/24/2003US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer
07/24/2003US20030139449 Anxiolytic agents; psychological disorders; cognition activators
07/24/2003US20030139425 Piperazine derivatives and their use as anti-inflammatory agents
07/24/2003US20030139423 Central nervous system disorders; psychological disorders
07/24/2003US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
07/24/2003US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product
07/24/2003CA2473374A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators